Litigation

$FDX Sues U.S. Government for Tariff Refunds Post-Supreme Court Ruling

Key Takeaways FedEx (FDX) has filed a lawsuit seeking a refund of tariffs imposed during the Trump administration, per court documents. The move follows a recent Supreme Court ruling that deemed the process used for certain tariffs illegal, according to legal analyses. The U.S. administration has cautioned that tariff refunds could take years to process,

$FDX Sues U.S. Government for Tariff Refunds Post-Supreme Court Ruling Read More »

Lupin’s $90 Million Astellas Settlement: Navigating the Complexities of Pharmaceutical Patent Litigation

India’s Lupin Limited recently settled a protracted patent infringement dispute with Japan’s Astellas Pharma in the United States, agreeing to pay $90 million to resolve claims related to Astellas’s blockbuster prostate cancer drug, Xtandi (enzalutamide). This significant financial resolution, announced to the market, aims to conclude the legal battle over Lupin’s proposed generic version of

Lupin’s $90 Million Astellas Settlement: Navigating the Complexities of Pharmaceutical Patent Litigation Read More »